Culture Development Featured Articles
-
CFDRC Developing Cell-Based Microchip To Study Drug Interactions With The Blood-Brain Barrier
6/21/2012
CFD Research Corporation (CFDRC) has been awarded a $1.3M grant from the National Institutes of Health to further develop their novelin vitro Blood-Brain Barrier model. Building upon CFDRC's patented and commercially available SynVivo platform, SynVivo-BBB is a cell-based microchip which allows co-culture of endothelial cells under physiological flow with neuronal and glial cells mimicking the in vivo environment.
-
TAP Biosystems Collaborates With OU To Develop Biomimetic 3D CNS Models Novel Approach Could Contribute To Reducing Number Of Pre-Clinical Animal Studies
5/10/2012
TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications, is pleased to announce that it is collaborating with scientists at The Open University (OU), in Milton Keynes, UK to produce robust 3D human central nervous system (CNS) tissue models for use in drug discovery and pre-clinical testing.
-
Irvine Scientific Announces Launch Of BalanCD® Cell Culture Media Product Line
4/3/2012
Irvine Scientific is pleased to announce the launch of their BalanCD® Cell Culture Media Product Line, a next generation cell culture product portfolio responding to today’s challenges for media used for industrial biopharmaceutical applications.
-
apceth And Indivumed To Develop Biomarker Platform For Targeted Cellular Therapies
2/23/2012
apceth GmbH & Co. KG, located in Munich, Germany, and Indivumed GmbH, based in Hamburg, Germany, have entered into a partnership for the development of a predominantly tissue-based biomarker strategy for the treatment of solid cancers with cellular and / or gene therapeutics.
-
Parallel Bioprocess Development Tool On Cell Culture Tubes
11/29/2011
Scientists and technicians working in the pharmaceutical industry will benefit from parallel monitoring of pH in up to 96 cell culture tubes.
-
Mirus Bio And Reinnervate Collaborate To Introduce The 3D Transfection System: Enabling Transfection Of Cells In 3D Culture
11/17/2011
Ideal for transfecting cells propagated in 3D cell culture, the new 3D Transfect ion System combines the technologies of Reinnervate’s alvetex 3D cell culture plates and Mirus Bio’s TransIT-3D Transfect ion Reagent, enabling scientists to conduct research that more accurately mimics the tissue environment.
-
Syntaxin And Ipsen Enter Into A Strategic Agreement To Develop Novel Botulinum-Toxin Therapeutics
10/21/2011
Ipsen and Syntaxin, a biotechnology company specialising in innovative biopharmaceutical therapies targeting cell secretion pathways, announced recently a global strategic collaboration to explore the discovery and development of new compounds in the field of botulinum toxins.
-
Key Considerations When Outsourcing Cell-Culture Medium Development
10/18/2011
Today, cell-culture media for biological manufacturing represents a sizable market of more than $500M, but more impressive is the cumulative value of therapeutic products enabled by these reagents, which totals more than $35B. Given the importance of these reagents, major suppliers, drug manufacturers, and other biotech companies continue to make significant investments to improve their cell-culture media platforms.
-
InVitria Taps Industry Expert To Launch Cell Culture Supplements Product Line
1/24/2011
InVitria announced the expansion of its sales and marketing team with the addition of Shawn Smith as Vice President, Sales & Marketing.
-
Nearly 100 New Medicines In Development For Alzheimer's
11/4/2010
As the champagne corks are popping this New Year’s Eve, the first American Baby Boomers will turn age 65. Members of the demographic bulge that transformed American politics and culture are expected to usher in yet another momentous change -- a huge increase in the number of Alzheimer's disease patients.